Navigation Links
Night Light Found To Increase The Risk Of Leukemia

According to a new study the healthiest environment for your child at bedtime would be a pitch-black room as researchers say increased light at night may put children at risk for leukemia.//

In the past, research has found a correlation between night workers and an increased risk for breast cancer, further supporting the theory that light at night is a risk factor for leukemia.

Researchers have determined that light at night is found to disrupt the circadian rhythm and suppress the production of melatonin. Researchers also says, "As an antioxidant, in many studies melatonin has been shown to protect DNA from oxidative damage. Once damaged, DNA may mutate and carcinogenesis may occur."

Thus researcher conclude saying that if melatonin levels are altered by magnetic fields, a potential relationship between these fields and cancer, including leukemia, would be possible.
'"/>




Page: 1

Related medicine news :

1. Night borns risk
2. Nightlights could ward diabetic blindness
3. Night Time Aspirin Regimen Found to Reduce Blood Pressure
4. Exposure To Night Light may Increase The Risk Of Leukemia
5. Understanding The Mystery Behind Sleepless Nights
6. Neonatal Risk Of Death Is More For Babies Born At Night
7. Drug Trial Turned Into a Terrible Nightmare
8. Secret Herb Could Tackle Hot Flushes And Night Sweats In Breast Cancer Patients
9. Melatonin Can Help Nighttime Workers Sleep
10. Increased Nighttime BP, a Significant Predictor of Congestive Heart Failure
11. Drug Trial Proves Nightmare for British Indian Student
Post Your Comments:
(Date:10/11/2008)... Barnett International, a division of ...d the release of The Form FDA 1572: A Reference Gu...rs. Designed for clinical investigators, clinical ...fessionals, and others involved in the clinical re...ide to address the Form FDA 1572-Statement of Inve...
(Date:10/10/2008)... to develop some form of disease by 20 years after...10 (HealthDay News) -- Liver transplant patients h...population, say researchers in Finland. , In a...r Transplantation , researchers investigated the c... recipients from Helsinki University Central Hospi...
(Date:10/10/2008)..., Wis., Oct. 10 /PRNewswire/ -- More than 600 new ...residential election. This is the,result of Aurora...hursday,Oct. 9, at all of the health care system,...f 658 people signed up to vote at the drives., Au... the Wisconsin,Government Accountability Board to ...
(Date:10/10/2008)... Upon the completion of a highly succe... CDM Media proudly announces their next business t...mation technology executives in healthcare. CDM Me...aunch May 10-12, 2009 at the Four Seasons Resort i...ulu, HI (PRWEB) October 11, 2008 -- Upon the compl...
Breaking Medicine News(10 mins):Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 2Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 3Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2
... nationwide Japanese encephalitis immunization pro...mani Ramadoss said// here Tuesday. The health mena...uitoes, had claimed over 1,000 lives, mostly in Ut...around 1,700 lives in 2004. "The initiative to be ...
... knowledge now about folic acid’s importance in di...d. Food Standards Agency would most likely// sanct...sumer research. The importance of folic acid lies...he risk of neural tube defects such as spina bifid...
...33, single young mother has died of a blood clot h...was admitted to Simpson's maternity// pavilion, pa...rly hours. Ms McIntosh already had a 17-month-old ...ed in her lung, known as a pulmonary embolism, and...
...sed with AIDS in the early 1990's when she was 35,..., who died years earlier// of AIDS related complic...ich gave her less than two years to live. One da...ositive people, she saw an advertisement offering ...
Other Medicine News:
(Date:10/9/2008)...rth American Campaign to Spread Awareness and Brin...N, Oct. 9 /PRNewswire-USNewswire/ -- 133 million c... due to causes such as natural,disaster, civil war...A) is,observing World Orphan Week by calling atten...the Multimedia News Release, go to:, http://www....
(Date:10/9/2008)...OCKHOLM, October 9 /- Diamy...l medical journal, the New England Journal,of Medi...he company,s study,of the Diamyd(R) diabetes vacci...om.com/cgi-bin/prnh/20080314/297194 ), The artic...tp://www.nejm.org ) and will be in print on Octobe...
(Date:10/8/2008)...w Zanolimumab Program to be Discontinued and Headc...Results of its Portfolio Review; Zanolimumab Prog... the Number of Emplo.../ -- Genmab A/S (OMX: GEN),announced today that it...x-CD4(R)). In addition, as a result of a portfolio...
(Date:10/8/2008)... Exploratory study shows clinical improvement in p...(PAH), -- Current treatment options have limite...ressive and incurable blood vessel disease, -- ...atment of certain cancers, known to inhibit p...her explore potential of imatinib mesylate in PAH ...
Breaking Medicine Technology:Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Tubbs Jones Votes to Support the Family Smoking Prevention and Tobacco Control Act 24698 1Stanford Accelerates Union Busting Tactics 24694 1House Passes Historic Bill to Protect Kids From Tobacco 3B Senator Sununu Should Cosponsor Legislation 24690 1House Passes Historic Bill to Protect Kids From Tobacco 3B Senator Sununu Should Cosponsor Legislation 24690 2China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 6835 1China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 6835 2China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 6835 3China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors 6835 4
...BUSINESS WIRE)--Apr 25, 2007 - Acorda,Therapeutics...Lauren Krupp, Professor of Neurology at Stony Broo...e 3 clinical trial of,Fampridine-SR in multiple sc... May 2, 2007. This reception will follow a present...ology (AAN) annual,meeting., Dr. Krupp,s presentat...
...o Assist in Design of Future Trials, Other,Program...l 26, 2007,/PRNewswire-FirstCall/ -- Iomai Corpora...hase 2 dose-ranging trial of its patch-based,vacci...d to assess,the ability of a range of vaccine dose...igenic E. coli (ETEC) bacteria -- the,most common ...
Other Medicine Technology:Acorda Therapeutics to Host Analyst and Investor Reception 2Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for,Travelers' Diarrhea Stimulates Immune Response Even at Low Doses 2Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for,Travelers' Diarrhea Stimulates Immune Response Even at Low Doses 3Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for,Travelers' Diarrhea Stimulates Immune Response Even at Low Doses 4
Demineralized bone matrix dispensed in a jar. Fibers will be free of foreign matter. Glycerol 70-88% by weight. Calcium content less than 8%.
Inductive demineralized bone matrix and conductive cancellous chips. DBM and cancellous chips will be free of foreign matter. Demineralized bone matrix particle size is 125 to 1000 . Cancellous chip
Demineralized Freeze-dried Bone Allograft (DFDBA) processed from cortical bone. Demineralized cortical powder is free of all soft tissue.
Dedicated ENT electromagnetic surgical navigation system. Value priced for comunity hospitals and surgical centers.
Medicine Products: